These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35486908)

  • 1. ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients.
    Liu D; Hao Q; Li J; Li Q; Wang K; Geng Q; Wu Y; Vadgama JV; Wu Y
    Cancer Commun (Lond); 2022 Jul; 42(7):663-667. PubMed ID: 35486908
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling.
    Lee HJ; Song IH; Park IA; Heo SH; Kim YA; Ahn JH; Gong G
    Oncotarget; 2016 May; 7(21):30119-32. PubMed ID: 27121061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells.
    Chen X; Ma N; Zhou Z; Wang Z; Hu Q; Luo J; Mei X; Yang Z; Zhang L; Wang X; Feng Y; Yu X; Ma J; Guo X
    Med Sci Monit; 2017 Jun; 23():2674-2683. PubMed ID: 28570501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.
    Cheriyath V; Kuhns MA; Jacobs BS; Evangelista P; Elson P; Downs-Kelly E; Tubbs R; Borden EC
    Oncogene; 2012 Apr; 31(17):2222-36. PubMed ID: 21996729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.
    Jiang HS; Kuang XY; Sun WL; Xu Y; Zheng YZ; Liu YR; Lang GT; Qiao F; Hu X; Shao ZM
    Oncotarget; 2016 Jul; 7(27):41285-41293. PubMed ID: 27285752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer.
    Hollmén M; Roudnicky F; Karaman S; Detmar M
    Sci Rep; 2015 Mar; 5():9188. PubMed ID: 25776849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of differentially expressed proteins between HER2 positive and triple negative breast cancer and their prognostic significance.
    Wei Z; Sijia F; Rui T; Yang L; Jianjun H; Bin W; Jing X
    Ann Diagn Pathol; 2021 Dec; 55():151834. PubMed ID: 34610510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer.
    Chavez KJ; Garimella SV; Lipkowitz S
    Breast Dis; 2010; 32(1-2):35-48. PubMed ID: 21778573
    [No Abstract]   [Full Text] [Related]  

  • 9. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon as a modifier of estrogen receptors.
    Dimitrov NV; Meyer CJ; Strander H; Einhorn S; Cantell K
    Ann Clin Lab Sci; 1984; 14(1):32-9. PubMed ID: 6198954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance.
    Takahashi M; Hayashida T; Okazaki H; Miyao K; Jinno H; Kitagawa Y
    Cancer Sci; 2014 Jun; 105(6):675-82. PubMed ID: 24698107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.
    Krishnamurti U; Wetherilt CS; Yang J; Peng L; Li X
    Hum Pathol; 2017 Jun; 64():7-12. PubMed ID: 28153508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
    Fan Y; Ding X; Xu B; Ma F; Yuan P; Wang J; Zhang P; Li Q; Luo Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2066. PubMed ID: 26579819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival time and molecular subtypes of breast cancer after radiotherapy in Thailand.
    Kongsiang A; Tangvoraphonkchai V; Jirapornkul C; Promthet S; Kamsa-Ard S; Suwanrungruang K
    Asian Pac J Cancer Prev; 2014; 15(23):10505-8. PubMed ID: 25556500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer.
    Egelston CA; Guo W; Tan J; Avalos C; Simons DL; Lim MH; Huang YJ; Nelson MS; Chowdhury A; Schmolze DB; Yim JH; Kruper L; Melstrom L; Margolin K; Mortimer JE; Yuan Y; Waisman JR; Lee PP
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 35132960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death.
    Choi HJ; Lui A; Ogony J; Jan R; Sims PJ; Lewis-Wambi J
    Breast Cancer Res; 2015 Jan; 17(1):6. PubMed ID: 25588716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of androgen receptor in triple negative breast cancer.
    Luo X; Shi YX; Li ZM; Jiang WQ
    Chin J Cancer; 2010 Jun; 29(6):585-90. PubMed ID: 20507730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
    Broselid S; Cheng B; Sjöström M; Lövgren K; Klug-De Santiago HL; Belting M; Jirström K; Malmström P; Olde B; Bendahl PO; Hartman L; Fernö M; Leeb-Lundberg LM
    Clin Cancer Res; 2013 Apr; 19(7):1681-92. PubMed ID: 23554355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].
    Guan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):196-9. PubMed ID: 18756935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.